Bayer and NHCS to set up Centre of Excellence for Explorative Cardiovascular Studies

Bayer and NHCS to set up Centre of Excellence for Explorative Cardiovascular Studies
17:03 | 18/12/2020
Bayer and National Heart Centre Singapore today announced that they have entered into a 5-year collaboration agreement to set up a Center of Excellence for Explorative Cardiovascular Studies.
Bayer and NHCS will collaborate on forming a better understanding of cardiovascular diseases in Asian patients. Photo: Freepik
Bayer and National Heart Centre Singapore (NHCS) will establish a Center of Excellence for Explorative Cardiovascular Studies with the aim of boosting patient-centricity in research and development (R&D) and improving treatment outcomes in cardiovascular disease (CVD) management.
Combining NHCS‘ vast experience in managing Asian CVD patients and clinical research and Bayer’s expertise in pharmaceutical R&D, the centre will generate and integrate high-quality patient data into early clinical research which will allow the better understanding of the underlying biology of CVDs. The results could potentially lead to future targeted therapies to address unmet medical needs in defined patient populations. Bayer will contribute S$5.4 million ($4.1) towards the set up of the centre.

Related Keywords

Singapore ,Philip Larsen ,Terrance Chua ,National Heart Centre Singapore ,Bayer Pharmaceuticals Division ,Department Of Cardiology ,Centre Of Excellence ,Clinical Research ,Explorative Cardiovascular ,Explorative Cardiovascular Studies ,Carolyn Lam ,Preclinical Research ,Bayer Pharmaceuticals ,சிங்கப்பூர் ,பிலிப் லார்சன் ,டெரன்ஸ் சுய ,தேசிய இதயம் மையம் சிங்கப்பூர் ,பேயர் மருந்துகள் பிரிவு ,துறை ஆஃப் இருதயவியல் ,மையம் ஆஃப் சிறப்பானது ,மருத்துவ ஆராய்ச்சி ,கரோலின் லாம் ,பேயர் மருந்துகள் ,